XCR4/ CXCL12轴与白血病复发的研究进展
Research progress on relationship between CXCR4/ CXCL12 axis and relapsed leukemia
趋化因子受体CXCR4与其特异性配体CXCL12结合,启动下游信号通路形成CXCR4/ CXCL12生物轴,在造血干细胞的归巢、再植及维持正常造血和造血微环境的稳定过程中发挥重要作用。CXCR4/ CXCL12轴同时也可促进白血病细胞存活、增殖、转移及耐药,因此与白血病髓内外复发关系密切。CXCR4的表达水平可作为判断白血病患者预后的重要指标之一,同时CXCR4抑制剂与常规化疗药物联合使用是白血病治疗的一个新方向。
he binding complex of chemokine receptor CXCR4 and its specific ligand CXCL12 triggers the downstream signaling pathway to form biological axis of CXCR4/CXCL12. The axis plays an important role in homing,repopulation of hematopoietic stem cells,as well as maintenance of normal hematopoiesis and homeostasis of hematopoietic microenvironment. Meanwhile, CXCR4/ CXCL12 axis also closely related with relapsed leukemia, since it may promote survival, proliferation, metastasis and drug resistance in leukemic cells. The expression level of CXCR4 could be regard as an important marker for predicting prognosis in patients with leukemia, therefore,the combination of CXCR4 inhibitors with routine chemotherapy may represent a powerful approach to the treatment of leukemia.
高瑞兰、姚红章
基础医学肿瘤学内科学
受体XCR4趋化因子CXCL12信号传导白血病肿瘤残余
ReceptorsCXCR4Chemokine CXCL12Signal TransductionleukemiaNeoplasmResidual
高瑞兰,姚红章.XCR4/ CXCL12轴与白血病复发的研究进展[EB/OL].(2011-03-08)[2025-08-02].http://www.paper.edu.cn/releasepaper/content/201103-312.点此复制
评论